|
US5853719A
(en)
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
|
US7585622B1
(en)
*
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
|
US6475789B1
(en)
*
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
|
IL129103A0
(en)
*
|
1996-10-01 |
2000-02-17 |
Geron Corp |
Human telomerase catalytic subunit and pharmaceutical compositions containing same
|
|
US6228640B1
(en)
|
1997-02-07 |
2001-05-08 |
Cem Cezayirli |
Programmable antigen presenting cell of CD34 lineage
|
|
US6977073B1
(en)
|
1997-02-07 |
2005-12-20 |
Cem Cezayirli |
Method for stimulating an immune response
|
|
US6251665B1
(en)
|
1997-02-07 |
2001-06-26 |
Cem Cezayirli |
Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom
|
|
US20050169898A1
(en)
*
|
1997-04-15 |
2005-08-04 |
Jianlin Gong |
Cell fusions and methods of making and using the same
|
|
US20020041868A1
(en)
*
|
1997-04-15 |
2002-04-11 |
Charles Nicolette |
Cell fusions and methods of making and using the same
|
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
|
US6977074B2
(en)
*
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
|
CA2347067C
(en)
|
1998-03-31 |
2013-09-17 |
Geron Corporation |
Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer
|
|
US7402307B2
(en)
*
|
1998-03-31 |
2008-07-22 |
Geron Corporation |
Method for identifying and killing cancer cells
|
|
US20030022854A1
(en)
*
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
|
US20040247662A1
(en)
*
|
1998-06-25 |
2004-12-09 |
Dow Steven W. |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
FR2785542B1
(fr)
*
|
1998-11-06 |
2001-02-09 |
Pf Medicament |
UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES
|
|
US7713739B1
(en)
*
|
2000-11-17 |
2010-05-11 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticle-based transfection and activation of dendritic cells
|
|
US7015204B1
(en)
*
|
1999-10-07 |
2006-03-21 |
Cornell Research Foundation, Inc. |
Protective immunity or immunological tolerance induced with RNA particularly total cellular RNA
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US6783939B2
(en)
*
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
|
EP1436413A2
(en)
*
|
2000-10-24 |
2004-07-14 |
Whitehead Institute For Biomedical Research |
Response of dendritic cells to a diverse set of pathogens
|
|
AU2002240197A1
(en)
*
|
2001-02-01 |
2002-08-12 |
Tanox, Inc. |
Methods to generate and identify monoclonal antibodies to a large number of human antigens
|
|
DE10112851C1
(de)
|
2001-03-16 |
2002-10-10 |
Gsf Forschungszentrum Umwelt |
Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen
|
|
EP1390076A4
(en)
*
|
2001-04-27 |
2004-12-15 |
Xcyte Therapies Inc |
Maturation of antigen-presenting cells with activated cells
|
|
GB0111015D0
(en)
*
|
2001-05-04 |
2001-06-27 |
Norsk Hydro As |
Genetic material
|
|
ES2340532T3
(es)
|
2001-06-05 |
2010-06-04 |
Curevac Gmbh |
Arnm con un contenido g/c aumentado que codifica para un antigeno bacteriano y utilizacion del mismo.
|
|
EP1432791B2
(en)
*
|
2001-09-06 |
2013-10-23 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
EP1442125A4
(en)
*
|
2001-10-04 |
2004-12-08 |
Carlos Estuard Aguilar-Cordova |
CHIMERAL VIRUS VECTORS FOR GENE THERAPY
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
CN1665523A
(zh)
*
|
2002-07-05 |
2005-09-07 |
杜克大学 |
血管免疫疗法
|
|
US20040161417A1
(en)
*
|
2002-08-14 |
2004-08-19 |
Eli Gilboa |
Method of enhancing CD4+ T cell responses
|
|
ES2375299T3
(es)
|
2002-09-12 |
2012-02-28 |
Oncotherapy Science, Inc. |
Péptidos kdr y vacunas que los contienen.
|
|
AU2003296439B2
(en)
*
|
2002-12-10 |
2009-05-07 |
Argos Therapeutics, Inc. |
In situ maturation of dendritic cells
|
|
CA2509973C
(en)
*
|
2002-12-13 |
2013-02-26 |
Alphavax, Inc. |
Multi-antigenic alphavirus replicon particles and methods
|
|
AU2003297041B2
(en)
*
|
2002-12-13 |
2009-02-26 |
Alphavax, Inc. |
Alphavirus particles and methods for preparation
|
|
EP2557164A1
(en)
*
|
2003-02-18 |
2013-02-13 |
Kevin M. Slawin |
Induced activation in dendritic cells
|
|
US20060134067A1
(en)
*
|
2003-02-18 |
2006-06-22 |
Maxcyte, Inc. |
Loading of cells with antigens by electroporation
|
|
JP2006518219A
(ja)
*
|
2003-02-18 |
2006-08-10 |
マックスサイト インコーポレーティッド |
電気穿孔法による細胞への抗原の負荷方法
|
|
EP1608762B1
(en)
*
|
2003-03-20 |
2014-01-08 |
Alphavax, Inc. |
Improved alphavirus replicons and helper constructs
|
|
ATE432285T1
(de)
*
|
2003-07-11 |
2009-06-15 |
Alphavax Inc |
Cytomegalovirusimpfstoffe, die auf dem alphavirus basieren
|
|
DE10335833A1
(de)
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
|
CN1882603A
(zh)
*
|
2003-11-25 |
2006-12-20 |
阿哥斯医疗公司 |
mRNA转染的抗原呈递细胞
|
|
US20050181035A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Dow Steven W. |
Systemic immune activation method using non CpG nucleic acids
|
|
EP1730263A4
(en)
*
|
2004-03-02 |
2008-01-23 |
Tsuneya Ohno |
METHODS AND COMPOSITIONS RELATING TO HYBRID CELL VACCINES FOR TREATMENT AND CANCER PREVENTION
|
|
AU2005245956B2
(en)
*
|
2004-05-18 |
2011-05-19 |
Alphavax, Inc. |
TC-83-derived alphavirus vectors, particles and methods
|
|
US20080293581A1
(en)
*
|
2004-05-24 |
2008-11-27 |
Rogler Charles E |
Rna Expression Microarrays
|
|
CA2504451A1
(en)
*
|
2004-08-10 |
2006-02-10 |
Geron Corporation |
Dendritic cell vaccines for treating cancer made from embryonic stem cells
|
|
PL1794327T3
(pl)
|
2004-09-14 |
2017-04-28 |
Argos Therapeutics, Inc. |
Niezależna od szczepu amplifikacja patogenów i szczepionki przeciwko nim
|
|
US20060216269A1
(en)
*
|
2004-09-17 |
2006-09-28 |
Kenichiro Hasumi |
Dendritic cell tumor injection (DCTI) therapy
|
|
US8076132B2
(en)
|
2004-09-17 |
2011-12-13 |
Hasumi International Research Foundation |
Dendritic cell tumor injection (DCTI) therapy
|
|
GB0501129D0
(en)
*
|
2005-01-19 |
2005-02-23 |
Ribostem Ltd |
Method of treatment by administration of RNA
|
|
EP2325305B1
(en)
|
2005-02-25 |
2014-02-12 |
Oncotherapy Science, Inc. |
Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides
|
|
SI2095822T1
(sl)
|
2005-02-28 |
2013-12-31 |
Oncotherapy Science, Inc. |
Peptidi epitopov, izpeljani iz receptorja 1 vaskularnega endotelijskega rastnega faktorja, in cepiva, ki vsebujejo te peptide
|
|
ES2650569T3
(es)
|
2005-04-08 |
2018-01-19 |
Argos Therapeutics, Inc. |
Composiciones de células dendríticas y métodos
|
|
HUE027330T2
(en)
|
2005-07-27 |
2016-09-28 |
Oncotherapy Science Inc |
The TOM34 gene for colon cancer
|
|
AU2006304573B2
(en)
|
2005-10-17 |
2012-05-24 |
Sloan Kettering Institute For Cancer Research |
WT1 HLA class II-binding peptides and compositions and methods comprising same
|
|
PL2010209T3
(pl)
|
2006-04-10 |
2017-04-28 |
Sloan Kettering Inst For Cancer Res |
Immunogeniczne peptydy WT-1 i sposoby ich użycia
|
|
CA2649325C
(en)
|
2006-04-14 |
2019-01-08 |
Epicentre Technologies Corporation |
Kits and methods for generating 5' capped rna
|
|
SI2051987T1
(sl)
|
2006-08-18 |
2015-02-27 |
Argos Therapeutics, Inc. |
Uporaba cd83 v kombinacijskih terapijah
|
|
KR101454287B1
(ko)
|
2006-10-17 |
2014-11-04 |
온코세라피 사이언스 가부시키가이샤 |
Ｍｐｈｏｓｐｈ1 또는 ｄｅｐｄｃ1 폴리펩티드를 발현하는 암에 대한 펩티드 백신
|
|
EP2465510B1
(en)
*
|
2006-10-19 |
2018-11-28 |
Baylor College Of Medicine |
Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
|
|
WO2008055354A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Université de Montréal |
Rna-loaded dendritic cell compositions for eliciting cd4+ t cell help and related methods
|
|
TWI615403B
(zh)
|
2007-02-21 |
2018-02-21 |
腫瘤療法 科學股份有限公司 |
表現腫瘤相關抗原之癌症的胜肽疫苗
|
|
TW201425333A
(zh)
|
2007-04-11 |
2014-07-01 |
Oncotherapy Science Inc |
腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗
|
|
NZ582495A
(en)
|
2007-06-21 |
2012-05-25 |
Alphavax Inc |
Promoterless cassettes for expression of alphavirus structural proteins
|
|
SG183717A1
(en)
|
2007-08-20 |
2012-09-27 |
Oncotherapy Science Inc |
Foxm1 peptide and medicinal agent comprising the same
|
|
US8513208B2
(en)
*
|
2008-02-28 |
2013-08-20 |
Argos Therapeutics, Inc. |
Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
|
|
EP3156069B8
(en)
|
2008-06-20 |
2020-10-21 |
Duke University |
Compositions, methods, and kits for eliciting an immune response
|
|
US20100203067A1
(en)
|
2008-09-22 |
2010-08-12 |
Baylor College Of Medicine |
Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
|
|
WO2010058023A1
(en)
|
2008-11-24 |
2010-05-27 |
Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt Gmbh |
High affinity t cell receptor and use thereof
|
|
TWI500932B
(zh)
|
2008-12-05 |
2015-09-21 |
Oncotherapy Science Inc |
Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
|
|
US8728806B2
(en)
|
2008-12-06 |
2014-05-20 |
The Board Of Regents, The University Of Texas System |
Methods and compositions related to Th-1 dendritic cells
|
|
TWI469791B
(zh)
|
2009-02-18 |
2015-01-21 |
Oncotherapy Science Inc |
Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
|
|
CN105601725B
(zh)
|
2009-03-18 |
2019-08-09 |
肿瘤疗法科学股份有限公司 |
Neil3肽及包含它的疫苗
|
|
TWI507204B
(zh)
|
2009-05-26 |
2015-11-11 |
Oncotherapy Science Inc |
Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
|
|
TW201136604A
(en)
|
2009-12-14 |
2011-11-01 |
Oncotherapy Science Inc |
TMEM22 peptides and vaccines including the same
|
|
MX344579B
(es)
|
2010-03-11 |
2016-12-19 |
Oncotherapy Science Inc * |
Peptidos hjurp y vacunas que incluyen los mismos.
|
|
TWI538685B
(zh)
|
2010-04-02 |
2016-06-21 |
腫瘤療法 科學股份有限公司 |
Ｅｃｔ２胜肽及含此胜肽之疫苗
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
SI3590949T1
(sl)
|
2010-10-01 |
2022-09-30 |
Modernatx, Inc. |
Ribonukleinske kisline, ki vsebujejo N1-metil-psevdouracil, in njihove uporabe
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
EP2557089A2
(en)
|
2011-07-15 |
2013-02-13 |
Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Compositions and methods for immunomodulation
|
|
US9458447B2
(en)
|
2011-08-12 |
2016-10-04 |
Oncotherapy Science, Inc. |
MPHOSPH1 peptides and vaccines including the same
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2763701B1
(en)
|
2011-10-03 |
2018-12-19 |
Moderna Therapeutics, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
US9427461B2
(en)
|
2011-10-28 |
2016-08-30 |
Oncotherapy Science, Inc. |
TOPK peptides and vaccines including the same
|
|
RU2649364C2
(ru)
|
2011-12-16 |
2018-04-02 |
Модерна Терапьютикс, Инк. |
Составы на основе модифицированного нуклеозида, нуклеотида и нуклеиновой кислоты
|
|
EP2802347B1
(en)
|
2012-01-13 |
2019-01-09 |
Memorial Sloan Kettering Cancer Center |
Immunogenic wt-1 peptides and methods of use thereof
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
EP3520821A1
(en)
|
2012-04-02 |
2019-08-07 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of biologics and proteins associated with human disease
|
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
|
WO2014010231A1
(en)
|
2012-07-10 |
2014-01-16 |
Oncotherapy Science, Inc. |
Kif20a epitope peptides for th1 cells and vaccines containing the same
|
|
SI2922554T1
(sl)
|
2012-11-26 |
2022-06-30 |
Modernatx, Inc. |
Terminalno modificirana RNA
|
|
US10815273B2
(en)
|
2013-01-15 |
2020-10-27 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 peptides and methods of use thereof
|
|
CA2898099C
(en)
|
2013-01-15 |
2025-09-16 |
Memorial Sloan Kettering Cancer Center |
Immunogenic wt-1 peptides and methods of use thereof
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
TWI658049B
(zh)
|
2013-03-12 |
2019-05-01 |
腫瘤療法 科學股份有限公司 |
Ｋｎｔｃ２胜肽及含此胜肽之疫苗
|
|
EP2968502B1
(en)
|
2013-03-14 |
2020-08-26 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling t cell proliferation
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
DK3004329T3
(da)
|
2013-06-05 |
2020-05-18 |
Bellicum Pharmaceuticals Inc |
Fremgangsmåder til induktion af delvis apoptose under anvendelse af caspasepolypeptider
|
|
HK1226299A1
(zh)
|
2013-09-24 |
2017-09-29 |
Duke University |
用於诱发免疫反应的组合物、方法及工具
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
ES2806575T3
(es)
|
2013-11-01 |
2021-02-18 |
Curevac Ag |
ARN modificado con propiedades inmunoestimuladoras disminuidas
|
|
AU2015218396A1
(en)
|
2014-02-14 |
2016-08-11 |
Bellicum Pharmaceuticals, Inc. |
Methods for activating T cells using an inducible chimeric polypeptide
|
|
US9610358B2
(en)
*
|
2014-04-17 |
2017-04-04 |
Marker Gene Technologies, Inc |
Targeted pharmacological chaperones
|
|
WO2016014613A1
(en)
*
|
2014-07-22 |
2016-01-28 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for cancer immunotherapy
|
|
AU2015300260B2
(en)
|
2014-08-04 |
2020-01-02 |
Oncotherapy Science, Inc. |
URLC10-derived peptide and vaccine containing same
|
|
KR20220155610A
(ko)
|
2014-08-04 |
2022-11-23 |
온코세라피 사이언스 가부시키가이샤 |
Koc1-유래 펩티드 및 이를 포함하는 백신
|
|
KR20170040315A
(ko)
|
2014-08-04 |
2017-04-12 |
온코세라피 사이언스 가부시키가이샤 |
Cdca1-유래 펩티드 및 이를 포함하는 백신
|
|
WO2016036746A1
(en)
|
2014-09-02 |
2016-03-10 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
|
|
KR20170078619A
(ko)
*
|
2014-09-17 |
2017-07-07 |
더 존스 홉킨스 유니버시티 |
항원-특이적 t 세포 식별, 농축, 및/또는 증식을 위한 시약 및 방법
|
|
HK1243631A1
(zh)
*
|
2014-10-27 |
2018-07-20 |
Fred Hutchinson Cancer Research Center |
用於提高过继细胞免疫疗法效力的组合物和方法
|
|
EP3215522B1
(en)
|
2014-11-03 |
2021-12-01 |
Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum |
T cell receptors directed against bob1 and uses thereof
|
|
JP2018090491A
(ja)
*
|
2015-04-01 |
2018-06-14 |
株式会社細胞治療技術研究所 |
癌ワクチンの製造方法、及び癌ワクチン
|
|
US11090332B2
(en)
*
|
2015-05-21 |
2021-08-17 |
Regen BioPharma, Inc. |
Antigen specific mRNA cellular cancer vaccines
|
|
JP6666094B2
(ja)
*
|
2015-09-15 |
2020-03-13 |
株式会社東芝 |
吸着支持装置、および物品把持装置
|
|
CN108137652B
(zh)
|
2015-10-08 |
2021-08-03 |
肿瘤疗法科学股份有限公司 |
Foxm1衍生的肽和包含它们的疫苗
|
|
US11780934B2
(en)
|
2016-02-05 |
2023-10-10 |
Institut Pasteur |
Use of inhibitors of ADAM12 as adjuvants in tumor therapies
|
|
JP7033549B2
(ja)
|
2016-05-04 |
2022-03-10 |
フレッド ハッチンソン キャンサー リサーチ センター |
細胞に基づくネオ抗原ワクチンおよびその使用
|
|
CN109414023A
(zh)
*
|
2016-06-29 |
2019-03-01 |
杜克大学 |
用嵌合脊髓灰质炎病毒激活抗原呈递细胞的组合物和方法
|
|
WO2019135701A1
(en)
*
|
2018-01-05 |
2019-07-11 |
Nilsson Rolf Jonas Andreas |
Endogenous tumor-derived circular rna and proteins thereof for use as vaccine
|
|
TW202023581A
(zh)
|
2018-08-02 |
2020-07-01 |
日商腫瘤療法 科學股份有限公司 |
來自cdca1的胜肽及含有此的疫苗
|
|
US20250144143A1
(en)
*
|
2023-11-06 |
2025-05-08 |
Immunitybio, Inc. |
Virally Educated T cells
|